Increased numbers of CD11c+ cells are found in the liver of mice under obese conditions17, and liver inflammation contributes to the progression from NAFLD (defined as the presence of ≥5% of hepatic steatosis) to NASH18. Here, ITGAX is linked to fatty liver disease.